Deep Intelligence Across Industries

Company Headquarters: Mayfield Heights, Ohio, US Founded: 1991 Workforce: 50+ Company Working: Datatrak Int. is into the core business of providing eClinical solutions and cloud solutions for the clinical trials industry. It helps companies to conduct clinical trials in the minimum time and with ease. It is involved in development and marketing of business analytics, clinical trial management system, electronic data capture, randomization and trial supply management, image data capture, risk-based monitoring, medical coding, lab admin (central and local labs), and safety management services. The company has a strong client base in more than 83 countries.

Company Headquarters: Pennsylvania, US Founded: 2000 Workforce: 501-1000 Company Working: CRF Health is involved in the development of electronic clinical outcome assessment (eCOA) solutions for the life sciences industry for inhouse or site-based phase I-IV clinical trials. The company offers ePRO solutions, electronic clinical outcome assessments, electronic clinical data management, clinical trial data management system, patient reported outcomes, eDiary, eClinical outcomes assessments, electronic clinical trial data capture, eConsent, electronic informed consent, and connected technology to clients. The company was a part of more than 800 clinical trials and has presence in more than 74 countries.

Company Headquarters: New Jersey, US Founded: 1987 Workforce: 4000+ Company Working: BioClinica, Inc. is a major player in the global eClinical solutions market. The company is committed to provide scientifically-driven services and technology-enabled services. It serves pharmaceutical, biotechnology, medical device companies, and contract research organizations to conduct clinical trials and provide assistance related to it such as medical image management, electronic image transport and archive solutions, electronic data capture, clinical data management, interactive voice and Web response, clinical trial supply forecasting tools, and clinical trial management software solutions. It has more than 400 clients and it had been involved in more than 4000 clinical trials in recent years. Medical image management, electronic image transport and archive solutions, electronic data capture, clinical data management, interactive voice and Web response, clinical trial supply forecasting tools, and clinical trial management software solutions are some solutions provided by the company. It has a strong presence in the Americas, Europe, and Asia-Pacific.

Company Headquarters: Philadelphia, Pennsylvania, US Founded: 1977 Workforce: 3,510+ Company Working: ERT Clinical is a technology and data company which helps its clients to minimize the uncertainty and risk in clinical trials. The company is involved in various clinical trials conducted in the last decade and holds a strong position in the market. It has more than 50 years of experience in the clinical trials segment. It uses its technology platform “Expert” to conduct clinical trials. In 2017 more than 60% FDA approvals were based on clinicals trials conducted by using ERT technology. It operates through business segments, namely, cardiac safety solutions, eCoa solutions, respiratory solutions, imaging solutions, trial oversight, business intelligence, post-approval, and patient support programs and provides technology, services, and clinical consulting to other companies. The primary customers of ERT clinical are pharmaceutical companies and major contract manufacturing organizations.

Company Headquarters: Bubendorf, Switzerland Workforce: ~ 600 Founded: 1990 Company Working: Carbogen Amcis AG operates as a subsidiary of Dishman Carbogen Amcis Ltd. in the global market. The company is actively engaged in providing drug development and commercialization services along with the to the pharmaceutical and biopharmaceutical companies. It also offers preclinical studies, clinical trials, and commercial use studies, and products including high-quality Cholesterol and Vitamin D. It has state of art manufacturing facilities located at Aarau, Neuland, Vionnaz, Manchester, and Bubendorf for manufacturing of products including Highly Potent API and Antibody Drug Conjugates (ADC).

Company Headquarters: Plankstadt, Germany Founded: 2006 Workforce: ~1,000-5,000 Company Working: CordenPharma International is a full-service partner in the cGMP contract development & manufacturing of APIs, drug products, pharma packaging services, supporting leading pharmaceutical & biotechnology companies to achieve product development for the treatment of various diseases. The company has a network of cGMP facilities across Europe and the US region, it has five technology platforms including peptides, highly potent & oncology, lipids & carbohydrates small molecules, antibiotics, and injectable.

Company Headquarters: Philadelphia, US Founded: 2017 Workforce: ~ 10-50 Company Working: Cabaletta Bio (Cabaletta) is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Our proprietary technology utilizes chimeric autoantibody receptor, or CAAR, T cells that are designed to selectively bind and eliminate B cells that produce disease-causing autoantibodies (pathogenic B cells) while sparing normal B cells. The company’s CABA platform, has applicability across more than two dozen B cell-mediated autoimmune diseases.

Company Headquarters: Ahmedabad, India Founded: 1984 Workforce: ~ 350 Company Working: Intas Pharmaceuticals Ltd (Intas) is a vertically integrated global pharmaceutical formulation developing, manufacturing, and marketing company. Intas has set up a network of subsidiaries, under the umbrella named Accord Healthcare to operate in global markets. Accord's portfolio comprises a multitude of different pharmaceutical forms, including, tablets, capsules, cytotoxic injectables, non- cytotoxic (ampoules), and controlled drugs.

Company Headquarters: South San Francisco, CA (US) Founded: 2008 Workforce: ~57 Company Working: Principia Biopharma (Principia) functions as a late-stage biopharmaceutical company focused on developing novel therapies for serious immune mediated diseases. The company offers and develops drugs for the treatment of cancer. The company serves the US market. Principia Biopharma patented tailored covalency platform allows to develop and design small covalent molecules.